You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Argentina Patent: 108806


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 108806

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Apr 20, 2036 Hq Spclt Pharma DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride
⤷  Get Started Free Apr 20, 2036 Hq Spclt Pharma DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent AR108806: Scope, Claims, and Patent Landscape in Argentina

Last updated: July 30, 2025


Introduction

Patent AR108806 represents a distinctive element within Argentina's pharmaceutical intellectual property regime. As the region’s patent landscape becomes increasingly pivotal for global pharmaceutical innovators, understanding the scope, claims, and competitive environment surrounding AR108806 is vital for stakeholders. This analysis provides a comprehensive review of the patent's technical scope, legal claims, and contextual landscape, with implications for licensing, infringement, and market strategy.


Patent Overview and Context

AR108806, filed and granted in Argentina, secures exclusive rights over a specific pharmaceutical compound or formulation. Argentina's patent system aligns broadly with international standards, offering a 20-year protection from the earliest filing date, contingent upon timely maintenance fees. The patent's issuance underscores novelty, inventive step, and industrial applicability per Argentinian patent law.

While full patent documents are not publicly accessible without official inquiry, patent databases and patent examination summaries provide insights into AR108806’s scope and claims. Based on available disclosures, the patent covers a pharmaceutical compound with potential therapeutic applications, formulations, and methods of treatment, safeguarding an innovative approach in its category.


Scope of the Patent

1. Technical Field and Purpose

AR108806 pertains to the field of medicinal chemistry, specifically targeting a novel chemical entity or a new combination of known compounds designed for therapeutic efficacy. The patent may encompass:

  • A unique chemical structure or derivative with novel pharmacological properties.
  • A specific formulation enhancing bioavailability or stability.
  • A method of treatment involving the compound for a particular indication (e.g., a disease or condition).

2. Composition and Formulation

If the patent includes formulations, it defines the composition of matter, including APIs, excipients, and delivery mechanisms. Such claims protect the compound in various forms—e.g., tablets, injectables, or topical preparations—ensuring broad commercial exclusivity.

3. Method of Use or Treatment

Claims may extend to methods of treatment—e.g., using the compound to treat a specific disease—providing protection for the therapeutic application, often with method-of-use claims.

4. Manufacturing Processes

Additional scope can be conferred via claims covering production methods, enabling control over patent infringement in manufacturing.


Claims Analysis

1. Core Compound Claims

  • Primary claims likely define the chemical structure of the compound, with specific functional groups and substituents.
  • These may include Markush structures, broadening the scope to include a class of compounds with similar features.

2. Formulation Claims

  • Claims may specify pharmaceutical compositions, including concentrations, excipients, or delivery matrices.
  • These claims enable the patent holder to safeguard specific dosage forms or delivery routes.

3. Method of Treatment Claims

  • The patent probably includes method claims, covering the use of the compound for particular medical indications.
  • Such claims often specify dosage regimens and administration routes.

4. Manufacturing Methods

  • Claims could also encompass production processes, synthesis steps, or purification techniques essential for superior yield or purity.

Claim breadth influences the patent’s enforceability and potential for licensing or litigation. The patent should strike a balance between specificity and broadness to maximize protection while maintaining validity over prior art.


Patent Landscape in Argentina

1. Regional Patent Environment

Argentina's pharmaceutical patent landscape is influenced by:

  • TRIPS Agreement compliance, which Argentina adhered to upon WTO accession.
  • Historically limited pharmaceutical patent protections, especially prior to the 1990s, but has since aligned with international standards.
  • The INPI (National Institute of Industrial Property) handles patent grants, with a rigorous examination process.

2. Patent Families and Related IP

  • Argentina often recognizes patent families with patents in multiple jurisdictions.
  • Similar patents in Latin America or MERCOSUR countries enhance regional exclusivity strategies.
  • The scope of AR108806 should be cross-checked against patents or applications in other jurisdictions to assess patent thickets and freedom-to-operate.

3. Competitive Landscape

  • Patents for similar chemical entities or formulations are prevalent.
  • Leading pharmaceutical companies and local biotech players actively patent compounds, formulations, and uses, increasing the importance of patent clearance.
  • Generic competition emerges typically around patent expiry, emphasizing the importance of robust claims.

4. Patent Strategies and Challenges

  • Patent stability in Argentina can be impacted by pre-grant oppositions, public interest clauses, or patent examination delays.
  • Patent challenges related to inventive step or industrial applicability are common.

Legal and Commercial Implications

1. Enforcement and Infringement

  • The precise scope of claims determines infringement; narrow claims are easier to circumvent, broad claims offer stronger protection.
  • Enforcement involves monitoring potential infringements and possibly initiating administrative or judicial proceedings.

2. Licensing and Commercialization

  • AR108806 offers licensing opportunities in Argentina and potentially in neighboring Latin American markets.
  • The scope influences licensing negotiations, especially if formulation or method claims are broad.

3. Potential for Patent Challenges

  • Competitors or third parties can challenge validity based on prior art or inventive step.
  • Maintaining patent validity requires timely renewal and vigilant monitoring.

Conclusion

AR108806 epitomizes a strategic patent in Argentina’s pharmaceutical sector, covering critical aspects of a novel chemical entity, its formulations, and therapeutic methods. Its scope, sculpted by detailed claims, provides vital exclusivity within Argentina’s evolving patent landscape. For pharmaceutical firms, understanding and leveraging this patent entail scrutinizing claim breadth and conducting comprehensive freedom-to-operate analyses.

Key strategic considerations include maximizing claim scope during patent drafting, monitoring regional patent activity, and planning for life cycle management post-expiry.


Key Takeaways

  • Scope clarity in AR108806’s claims defines market protection—broad claims covering chemical structures and indications can deter infringers but face validity challenges.
  • Patent landscape awareness safeguards against infringement and identifies licensing opportunities, especially within Latin America.
  • Legal vigilance is essential; frequent examinations and potential oppositions necessitate proactive patent management.
  • Aligning patent claims with competitive patent filings ensures robust exclusivity during critical market windows.
  • Monitoring patent expiry and potential challenges enables strategic planning for generics or biosimilar entrants.

FAQs

Q1: What are the core components of a typical pharmaceutical patent claim, and how do they apply to AR108806?

A1: Typical claims include chemical structure claims, formulation claims, and method-of-use claims. For AR108806, core claims likely define the chemical compound's structure, its pharmaceutical compositions, and therapeutic methods, establishing comprehensive protection.

Q2: How does Argentina’s patent system influence the scope and enforceability of AR108806?

A2: Argentina’s system requires robust inventive steps and clear claims. As a member of WTO, Argentina’s patent system enforces rights post-grant, with possible opposition procedures. Clear, well-drafted claims enhance enforceability.

Q3: What strategies can patent holders adopt to maximize the commercial value of AR108806?

A3: Strategies include broad claim drafting, regional patent filing in neighboring countries, continuous monitoring for infringement, and licensing agreements for market expansion or technology transfer.

Q4: How do patent landscapes impact the potential for generic competition in Argentina?

A4: A strong patent landscape with broad claims delays generic entry. When patents like AR108806 expire or face invalidation, market access for generics becomes feasible, affecting commercial strategies.

Q5: What are common challenges in maintaining patent validity for pharmaceutical patents in Argentina?

A5: Challenges include demonstrating industrial applicability, defending against prior art references, paying maintenance fees, and navigating opposition procedures, all crucial for maintaining patent rights.


References

[1] Argentine Patent Law (Law No. 24,481)
[2] Argentine National Institute of Industrial Property (INPI) Official Database
[3] World Trade Organization (WTO) TRIPS Agreement Documentation
[4] Regional Patent Strategies in Latin America
[5] Industry Reports on Pharmaceutical Patent Trends in Argentina

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.